Terms: = Pancreatic cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Prognosis
3 results:
1. Fructose-1,6-bisphosphatase 1 (FBP1) is an independent biomarker associated with a favorable prognosis in esophageal adenocarcinoma.
Damanakis A; Plum PS; Gebauer F; Schröder W; Büttner R; Zander T; Bruns CJ; Quaas A
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2287-2293. PubMed ID: 35477823
[TBL] [Abstract] [Full Text] [Related]
2. Cytopathological Heterogeneity of Circulating Tumor Cells in Non-metastatic Esophageal Adenocarcinoma.
Kuvendjiska J; Pitman MB; Martini V; Braun C; Grebe K; Timme S; Fichtner-Feigl S; Glatz T; Schmoor C; Guenzle J; Hoeppner J; Kulemann B
Anticancer Res; 2020 Oct; 40(10):5679-5685. PubMed ID: 32988893
[TBL] [Abstract] [Full Text] [Related]
3. Donor one‑carbon metabolism gene single nucleotide polymorphisms predict the susceptibility of cancer recurrence after liver transplantation.
Wang C; Lu D; Ling Q; Chen J; Liu Z; Guo H; Xu X; Zheng S
Gene; 2019 Mar; 689():97-101. PubMed ID: 30529095
[TBL] [Abstract] [Full Text] [Related]
